Comparison Across Treatment Conditions to Reduce Smokeless Tobacco Use
Completed · Phase 2
Conditions studied: Tobacco Use Disorder
In brief
Smokeless tobacco (ST), which includes both chewing tobacco and snuff, has health risks associated with its use. While treatment programs that focus on stopping tobacco use may be effective, past research has shown that interventions that specifically focus on reducing tobacco use may be equally effective and may motivate individuals to eventually quit using tobacco. This study will compare the effectiveness of a ST reduction treatment program versus a usual tobacco cessation treatment program (immediate cessation) for reducing tobacco use in ST users.
Key facts
- Study ID
- NCT00218296
- Run by
- University of Minnesota
- People needed
- 332
- Starts
- 2006-11-01
- Expected to finish
- 2009-01-01
- Last updated by the study team
- 2017-10-16
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- No interest in stopping ST use within 90 days of study entry
- Daily use of ST in the 6 months prior to study entry
You may not qualify if…
- Current use of tobacco or nicotine products, other than ST
- Current unstable medical and mental health conditions
- Use of any medication that may affect tobacco use or be affected by a reduction in tobacco use
- Pregnant or breastfeeding
Where it is running
- Univerisity of Minnesota — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.